Table 2 Responses to immunotherapy
RECIST v1.1 | All treated patients (n = 152) |
|---|---|
Best response | |
Complete response | 4 (3%) |
Partial response | 22 (14%) |
Stable disease | 66 (43%) |
Progressive disease | 54 (36%) |
Not evaluable | 6 (4%) |
Overall response rate | 17% (95% CI, 11–22) |
Disease control rate | 60% (95% CI, 52–68) |
Median time to response | 2.0 months |
Median duration of response | 6.2 months |